CIP
AMGN icon

Chartwell Investment Partners’s Amgen AMGN Stock Holding History

Chartwell Investment Partners’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,816
Closed -$701K – 426
2021
Q1 		$701K Sell
2,816
-195
-6% -$46.5K 0.02% 381
2020
Q4 		$692K Buy
3,011
+91
+3% +$21K 0.02% 384
2020
Q3 		$742K Hold
2,920
– – 0.03% 372
2020
Q2 		$689K Buy
+2,920
New +$666K 0.03% 358

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Chartwell Investment Partners's AMGN Position: Q2 2021 in Review

Chartwell Investment Partners sold out of Amgen (AMGN) in Q2 2021, closing a stake of 2,816 shares — an estimated $701K sold.

Chartwell Investment Partners first reported a position in AMGN in Q2 2020 and held it in 4 quarters. The position peaked at $742K in Q3 2020. 2,194 funds tracked by Wall St. Rank hold AMGN as of Q2 2021.

  • Chartwell Investment Partners reported no remaining Amgen position as of Q2 2021 after selling out during the quarter.
  • Chartwell Investment Partners sold 2,816 Amgen shares in Q2 2021, an estimated $701K.
  • Chartwell Investment Partners first reported a position in Amgen in Q2 2020 and held it in 4 quarters.
  • Chartwell Investment Partners's Amgen position peaked at $742K in Q3 2020.
  • 2,194 funds tracked by Wall St. Rank held Amgen as of Q2 2021.

Based on Chartwell Investment Partners's 13F filing for Q2 2021, filed 19 Jul 2021.